Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study

AIM: Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial fibrillation undergoing cardioversion. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallisgaard, Jannik Langtved, Lindhardt, Tommi Bo, Hansen, Morten Lock, Schjerning, Anne-Marie, Olesen, Jonas Bjerring, Staerk, Laila, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625957/
https://www.ncbi.nlm.nih.gov/pubmed/26513589
http://dx.doi.org/10.1371/journal.pone.0141377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625957/
https://www.ncbi.nlm.nih.gov/pubmed/26513589
http://dx.doi.org/10.1371/journal.pone.0141377

Ejemplares similares